Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 34.95
Key Takeaways
Risk factor
Fair trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very strong margins and returns
Data is available to registered users only
Data is available to registered users only
About
Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells Chinese medicines in China. It offers pediatric drugs under the Jianmin and Longmu brands. The company also provides OTC, medical, and health products, as well as consultation service. Jianmin Pharmaceutical Group Co.,Ltd. is headquartered in Wuhan, China.
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. In particular, the stock is underpriced on P/E, of fair value on
Data is available to registered users only
Buy
Sell